uBriGene offers GMP manufacturing platforms for RNA therapeutics. Our LNP microfluidic system ensures batch consistency, control, and high yields.
uBriGene offers a range of GMP RNA-LNP manufacturing platforms, including mRNA, circRNA, and saRNA services. These platforms enable large-scale GMP RNA-LNP production via in vitro transcription (IVT), delivering high-yield, high-purity RNA-LNP therapeutic drug products.
Highly efficient GMP mRNA-LNP production platform with innovative RNA and LNP testing technologies.
circRNA platform ensures the production of high-quality (>90% purity), high expression, potency, and safe circRNA therapeutics.
View GMP circRNA-LNP ServicesInnovative self-amplifying RNA (saRNA) production platform delivering high-quality saRNA therapeutic products with >80% integrity.
Explore uBriGene’s robust GMP mRNA-LNP manufacturing process and testing capabilities.
Unveil the current manufacturing approaches for LVV and its deployment in cell therapies.
Learn about CAR-T production process & regulatory guidelines.
